Search the Newsreel

Nephrocare Health Services Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

SAPR11 - Sanepar - Resultados, Dividendos, Cotação e Indicadores

Nephros (NEPH) director Arthur Amron granted 2,418 shares, holds 140,874

Nephros Inc. director Arthur H. Amron was granted 2,418 shares of Common Stock on August 12, 2026, as compensation for his board service, increasing his direct holdings to 140,874 shares. He also holds stock options for 7,323 shares fully vested at an exercise price …

Neptune Insurance (NP) CFO James Steiner reports 100,000-share stock sale

Neptune Insurance Holdings Inc. CFO and director James Steiner sold a total of 100,000 shares of Class A Common Stock in two separate open-market transactions on August 12 and August 13, 2026. The sales were executed at weighted average prices of $31.0755 and $31.7121 …

Northland Securities Maintains Nephros(NEPH.US) With Hold Rating, Raises Target Price to $4.75

Northland Securities has reiterated its Hold rating on Nephros (NEPH.US) but raised the price target to $4.75. This adjustment indicates a slightly more optimistic outlook on the company's future stock performance by the firm.

August 2026's Promising Penny Stocks

This article highlights three promising penny stocks for August 2026: Nephros (NEPH), Siebert Financial (SIEB), and Douglas Elliman (DOUG). It examines their financial health, recent performance, and strategic initiatives, noting that these companies offer potential for growth despite being smaller or newer entities. The …

Sanepar registra prejuízo de R$ 505,2 milhões no 2T26

Smith & Nephew GAAP EPS of $0.36, revenue of $1.6B

* Smith & Nephew press release [https://seekingalpha.com/filing/309951347] (SNN [https://seekingalpha.com/symbol/SNN]): Q2 GAAP EPS of $0.36. * Revenue of $1.6B (+3.2% Y/Y). * Trading profit for the first half reached $566M, an 8.10% increase year-over-year, expanding the trading profit margin by 60 bps to 18.30%. * …

Smith+Nephew (SNN) lifts H1 2026 profit but cuts revenue growth outlook

Smith+Nephew reported a higher profit for the first half of 2026, with revenue reaching $3,097 million, an increase of 4.6% year-on-year, and trading profit up 8.1% to $566 million. Despite this profit growth, the company revised its full-year underlying revenue growth guidance downwards from …

Smith & Nephew SNATS, Inc. $SNN Shares Sold by Bank of America Corp DE

Bank of America Corp DE reduced its stake in Smith & Nephew SNATS, Inc. (NYSE:SNN) by 12.5% in the first quarter, selling 176,622 shares but still retaining over 1.2 million shares valued at approximately $39.4 million. Despite this sale, several other institutional investors increased …

Sanepar (SAPR4) registra prejuízo de R$ 505 mi no 2T26

Nepi Rockcastle to Buy Shopping Center in Spain for EUR254 Million

Smith & Nephew (SNN): executive share awards vest, partial sale to cover tax

Smith & Nephew plc reported that performance share awards granted in 2023 to Rohit Kashyap, President of Advanced Wound Management and Global Commercial Operations, vested on August 12, 2026. Of the 23,202 ordinary shares that vested, 9,163 were sold to cover tax liabilities, with …

REG - Smith & Nephew Plc - Director/PDMR Shareholding

Smith & Nephew Plc has announced transactions made by Persons Discharging Managerial Responsibilities (PDMRs) and closely associated persons following the vesting of awards under its Global Share Plan 2020 and Restricted Share Plan 2024. The announcement details the vesting of 2023 Performance Share Awards, …

Cevian increases Smith & Nephew (NYSE: SNN) holding to 14.21% of votes

Cevian Capital II G.P. Limited has increased its aggregate holding in Smith & Nephew plc to 14.214414% of voting rights, corresponding to 119,179,419 shares. This represents a slight increase from its previously notified holding of 14.010786%, with the additional shares held through Cevian Capital …

REG - Smith & Nephew Plc - Holding(s) in Company

Cevian Capital II GP Limited has notified a change in its major holdings in Smith & Nephew Plc, with its total voting rights now at 14.214414%. This increase is primarily due to an increased stake via Cevian Capital II Master Fund L.P., though the …

NEPHROPLUS: Q1 FY 2027 delivered strong revenue and margin growth, with robust international expansion

NEPHROPLUS: Revenue grew 23.7% and adjusted EBITDA 31% year-on-year, with strong international expansion

Smith & Nephew (SNN) Q2 2026 Earnings Call Transcript

Q2 2026 Cineplex Inc Earnings Call Transcript

Earnings Flash (CGX.TO) Cineplex Inc. Reports Q2 Revenue C$383.7M, vs. FactSet Est of C$378.7M

Neptune Insurance Holdings Inc. $NP Stock Holdings Lifted by Sei Investments Co.

Smith & Nephew SNATS, Inc. (SNN) Stock Forecasts

Nephros (NEPH) boosts Q2 2026 profit on revenue growth and tariff refund

Nephros Inc. (NEPH) reported significant financial growth in Q2 2026, with net revenue up 36% to $6.0 million and net income rising to $1.2 million, largely driven by programmatic product growth and a $0.6 million IEEPA tariff refund. Despite this positive performance, the company …

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Healthcare Innovator with a 12.53% Upside Potential

Smith & Nephew SNATS, Inc. (SNN) is a healthcare innovator with a robust market presence and promising growth potential, offering a 12.53% upside potential based on analyst ratings. The company boasts strong financial health with over $1 billion in free cash flow, 4.60% revenue …

NEPI Rockcastle Unit Signs EUR250 Million Green Term Loan Facility

NEPI Rockcastle N : Secures A EUR 250 Million Green Term Loan From The EBRD

Smith & Nephew SNATS Q2 Earnings Call Highlights

Neptune Insurance Holdings Ord Shs Class A (NP) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Neptune Insurance Holdings Ord Shs Class A (NP), including future EPS and revenue growth estimates. Based on 14 analysts, the stock has a "Buy" rating with a target price of $34.417, representing a 4.83% upside. The expected …

Smith & Nephew Is Under Pressure from External Factors and Portfolio Gaps

Smith & Nephew (SNN) is facing pressure due to external factors and gaps in its product portfolio, despite its history of innovation in orthopedics, sports medicine, and wound care markets. The company has shown strength in introducing innovations like Oxinium technology for hip replacements …

Press Release: Nephros Announces Strong Financial Results for Quarter Ended June 30, 2026

Nephros announced strong financial results for the quarter ended June 30, 2026. The company reported significant revenue growth and improved profitability, driven by strong demand for its innovative filtration products. Management expressed optimism about future growth prospects and their ability to continue delivering value …

Nephros Inc (NEPH) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Nephros Inc (NEPH), detailing its current earnings forecast score, average price target, and analyst ratings. It highlights that three analysts rate NEPH as a "Buy" with an average price target of $7.00. The forecast also includes expected …

Smith & Nephew Earnings: Weakness in First Half Could Linger in Second Half